Similar articles

• [Role of new anti-inflammatory agents in rheumatologic practice].

  Boutelier D. Boutelier D. Therapeutique. 1969 Dec;45(10):1033-5. Therapeutique. 1969. PMID: 5311447 French. No abstract available.
• [Our experiences in the treatment of rheumatic diseases by Perclusone ointment].

  Androić S. Androić S. Reumatizam. 1974;21(6):228-30. Reumatizam. 1974. PMID: 4445615 Croatian. No abstract available.
• [Treatment of the diseases of the extended rheumatic sphere form with paracetamol (Dolo-arthrosetten)].

  Finkbeiner G. Finkbeiner G. Munch Med Wochenschr. 1973 Oct 19;115(42):1855-7. Munch Med Wochenschr. 1973. PMID: 4129251 Clinical Trial. German. No abstract available.
• The 'side effects' of rheumatoid arthritis: joint destruction, disability and early mortality.

  Pincus T, Callahan LF. Pincus T, et al. Br J Rheumatol. 1993 Mar;32 Suppl 1:28-37. Br J Rheumatol. 1993. PMID: 8448634 Review.
• Nonsteroidal anti-inflammatory drugs and modulation of cartilaginous changes in osteoarthritis and rheumatoid arthritis. Clinical implications.

  Herman JH, Hess EV. Herman JH, et al. Am J Med. 1984 Oct 15;77(4B):16-25. doi: 10.1016/s0002-9343(84)80087-x. Am J Med. 1984. PMID: 6388322 Review.